Revefenacin is a selective muscarinic M3 receptor antagonist indicated for the treatment of chronic obstructive pulmonary disease (COPD), where it functions by relaxing airway smooth muscle to improve… Read more
![Chemical structure of 1-(2-(4-((4-(((4-((2-(4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)phenyl)(hydroxy)methyl)carbamoyl)piperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2-4-4-4-2-4-11-Biphenyl-2-ylcarbamoyloxypiperidin-1-ylethylmethylcarbamoylphenylhydroxymethylcarbamoylpiperidin-1-ylmethyl-N-methylbenzamidoethylpip.png&w=3840&q=75)
![Chemical structure of 1-(2-(4-((4-(Aminomethyl)piperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2-4-4-Aminomethylpiperidin-1-ylmethyl-N-methylbenzamidoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(4-((4-Carbamoylpiperidin-1-yl)(hydroxy)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2-4-4-Carbamoylpiperidin-1-ylhydroxymethyl-N-methylbenzamidoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(4-((4-Carbamoylpiperidin-1-yl)methyl)benzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F864751-29-1-1-2-4-4-Carbamoylpiperidin-1-ylmethylbenzamidoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(4-(hydroxymethyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1682660-39-4-1-2-4-hydroxymethyl-N-methylbenzamidoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(4-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F864760-28-1-1-2-4-formyl-N-methylbenzamidoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(Methyl(nitroso)amino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2-Methylnitrosoaminoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F743460-48-2-1-2-methylaminoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(2-(N,4-Dimethylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-2-N4-Dimethylbenzamidoethylpiperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)
![Chemical structure of 1-(4-((2-(4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)-4-carbamoylpiperidine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3001303-52-9-1-4-2-4-11-Biphenyl-2-ylcarbamoyloxypiperidin-1-ylethylmethylcarbamoylbenzyl-4-carbamoylpiperidine-1-oxide.png&w=3840&q=75)
![Chemical structure of 1-(4-((2-(4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzyl)piperidine-4-carboxylic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F909800-36-8-1-4-2-4-11-Biphenyl-2-ylcarbamoyloxypiperidin-1-ylethylmethylcarbamoylbenzylpiperidine-4-carboxylic-acid.png&w=3840&q=75)





![Chemical structure of 4-((2-(4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)carbamoyl)benzoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-2-4-11-Biphenyl-2-ylcarbamoyloxypiperidin-1-ylethylmethylcarbamoylbenzoic-Acid.png&w=3840&q=75)

![Chemical structure of 4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)-1-(2-(4-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F3001303-50-7-4-11-Biphenyl-2-ylcarbamoyloxy-1-2-4-4-carbamoylpiperidin-1-ylmethyl-N-methylbenzamidoethylpiperidine-1-oxide.png&w=3840&q=75)
![Chemical structure of 4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)-1-(2-(4-((4-carbamoylpiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidine 1-oxide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F4-11-Biphenyl-2-ylcarbamoyloxy-1-2-4-4-carbamoylpiperidin-1-ylmethyl-N-methylbenzamidoethylpiperidine-1-oxide.png&w=3840&q=75)
![Chemical structure of [1,1'-Biphenyl]-2-yl (1-(2-(3-([1,1'-biphenyl]-2-yl)-1-methylureido)ethyl)piperidin-4-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F11-Biphenyl-2-yl-1-2-3-11-biphenyl-2-yl-1-methylureidoethylpiperidin-4-ylcarbamate.png&w=3840&q=75)
![Chemical structure of [1,1'-biphenyl]-2-ylcarbamic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F50443-60-2-11-biphenyl-2-ylcarbamic-acid.png&w=3840&q=75)


![Chemical structure of Desamino-hydroxy-des(1'-(N-([1,1'-biphenyl]-2-yl)formamidyl)) Revefenacin](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDesamino-hydroxy-des1-N-11-biphenyl-2-ylformamidyl-Revefenacin.png&w=3840&q=75)
![Chemical structure of Piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F171722-92-2-Piperidin-4-yl-11-biphenyl-2-ylcarbamate.png&w=3840&q=75)

Revefenacin is a selective muscarinic M3 receptor antagonist indicated for the treatment of chronic obstructive pulmonary disease (COPD), where it functions by relaxing airway smooth muscle to improve lung function. This category provides a comprehensive selection of Revefenacin reference standards, including the active pharmaceutical ingredient, identified impurities, potential metabolites, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these materials to support rigorous analytical testing, including impurity profiling and method validation during quality control processes. By providing high-quality reference materials, these compounds enable accurate quantification and structural identification, ensuring the efficacy and safety of drug formulations throughout the development cycle.